γ-Hydroxybutyrate (GHB), anticonvulsants, and α2-agonists have been studied as stand-alone or adjunctive agents in the treatment of alcohol withdrawal syndrome. Although these medications are promising for mild to moderate alcohol withdrawal syndrome, there is a dearth of information about their ability to prevent or treat complicated alcohol withdrawal.Alcohol Disorders: Practical Tips From New Research
Показаны сообщения с ярлыком празозин. Показать все сообщения
Показаны сообщения с ярлыком празозин. Показать все сообщения
четверг, 4 октября 2012 г.
Современные лекарственные стратегии лечения алкоголизма
четверг, 14 июня 2012 г.
Празозин как препарат выбора при ночных кошмарах в структуре ПТСР
Prazosin is an α1-adrenergic receptor antagonist with good CNS penetrability. The rationale for reducing adrenergic activity to address intrusive PTSD symptoms has been well documented. In open-label trials, a chart review, and placebo-controlled trials,prazosin reduced trauma nightmares and improved sleep quality and global clinical status more than placebo. In these studies, prazosin doses ranged from 1 to 20 mg/d, with an average of 3 mg at bedtime and a starting dose of 1 mg. Prazosin is the only agent recommended in the AASM’s Best Practice Guide for treating PTSD-related nightmares.PTSD nightmares: Prazosin and atypical antipsychotics
воскресенье, 11 марта 2012 г.
Празозин как средство от ночных кошмаров
Mayo Clinic investigators have completed a systematic literature review of prazosin in the treatment of nightmares. Researchers investigated 12 prazosin studies, four of which were randomized controlled trials.Blood Pressure Drug Relieves PTSD Nightmares
“The studies showed the drug was well-tolerated and can take effect rapidly, within days to weeks, and some patients reported a return of nightmares when the course of prazosin was stopped,” said Simon Kung, M.D., principal investigator of the study.
Подписаться на:
Сообщения (Atom)